Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
Authors
Keywords
Ovarian cancer, Chemotherapy resistance, Cisplatin, Cucurbitacin B, Dyrk1B
Journal
TUMOR BIOLOGY
Volume 37, Issue 1, Pages 685-698
Publisher
Springer Nature
Online
2015-08-04
DOI
10.1007/s13277-015-3773-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells
- (2013) Zhiqiang Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets
- (2013) Hina Kausar et al. CANCER LETTERS
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- Biological activities and potential molecular targets of cucurbitacins
- (2012) Xiuping Chen et al. ANTI-CANCER DRUGS
- Glutathione levels in human tumors
- (2012) Michael P. Gamcsik et al. BIOMARKERS
- Reactive Oxygen Species in Health and Disease
- (2012) Assim A. Alfadda et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest
- (2012) Suwit Duangmano et al. Journal of Oncology
- Molecular approaches to personalizing management of ovarian cancer
- (2011) R. C. Bast ANNALS OF ONCOLOGY
- In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines
- (2011) Judit Bartalis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
- (2011) Dhong Hyun Lee et al. CANCER LETTERS
- Expression of Poly (Adenosine Diphosphate-Ribose) Polymerase and p53 in Epithelial Ovarian Cancer and Their Role in Prognosis and Disease Outcome
- (2011) Heidi Godoy et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Cucurbitacin B suppresses the transactivation activity of RelA/p65
- (2011) Hong Ri Jin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
- (2011) Marcin P. Iwanicki et al. Cancer Discovery
- High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
- (2010) Yi-Chung Tung et al. ANALYST
- Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
- (2010) Gabriela B Iwanski et al. BRITISH JOURNAL OF PHARMACOLOGY
- Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells
- (2010) Lijun Tan et al. CANCER
- Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
- (2010) Christina M. Annunziata et al. CANCER
- Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration
- (2010) Kin Tak Chan et al. CANCER LETTERS
- Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
- (2010) Tingyan Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer
- (2009) Hong Zheng et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562
- (2009) Kin Tak Chan et al. CANCER LETTERS
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started